These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 19265346

  • 1. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ, Clarke K.
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM, Valeriano J, Vasey FB, Carter JD.
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [Abstract] [Full Text] [Related]

  • 3. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [Abstract] [Full Text] [Related]

  • 4. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J.
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [Abstract] [Full Text] [Related]

  • 5. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
    Wall E, Walker-Bone K.
    QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
    Gera C, Vij AS.
    Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
    [Abstract] [Full Text] [Related]

  • 7. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR, Shrader SP, Ragucci KR.
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [Abstract] [Full Text] [Related]

  • 8. Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.
    Caballero-Uribe CV, Acosta-Velez JG, Hernandez-Ruiz EA, Andrade Rodado FM, Peñuela-Epalza M.
    J Clin Rheumatol; 2008 Jun; 14(3):153-5. PubMed ID: 18525434
    [Abstract] [Full Text] [Related]

  • 9. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.
    Solomon DH, Katz JN, Cabral D, Patrick AR, Bukowski JF, Coblyn JS.
    Arthritis Rheum; 2006 Dec 15; 55(6):873-7. PubMed ID: 17139663
    [Abstract] [Full Text] [Related]

  • 10. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN.
    Minerva Med; 2008 Feb 15; 99(1):23-43. PubMed ID: 18299694
    [Abstract] [Full Text] [Related]

  • 11. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK.
    Cleve Clin J Med; 2010 Aug 15; 77(8):529-36. PubMed ID: 20682515
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoid-induced osteoporosis in dermatologic practice: a review.
    Khan YK, Kalaaji AN, Clarke BL.
    J Drugs Dermatol; 2008 Nov 15; 7(11):1053-9. PubMed ID: 19110736
    [Abstract] [Full Text] [Related]

  • 13. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH, Werth VP.
    Semin Cutan Med Surg; 2007 Dec 15; 26(4):203-9. PubMed ID: 18395668
    [Abstract] [Full Text] [Related]

  • 14. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
    McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA, Boire G, Haraoui B, Ferland DS, Keystone EC, Pope JE, CATCH Investigators.
    Rheumatology (Oxford); 2012 Sep 15; 51(9):1662-9. PubMed ID: 22539481
    [Abstract] [Full Text] [Related]

  • 15. Barriers in the management of glucocorticoid-induced osteoporosis.
    Guzman-Clark JR, Fang MA, Sehl ME, Traylor L, Hahn TJ.
    Arthritis Rheum; 2007 Feb 15; 57(1):140-6. PubMed ID: 17266078
    [Abstract] [Full Text] [Related]

  • 16. Prevention of corticosteroid-induced osteoporosis: results of a patient survey.
    Buckley LM, Marquez M, Feezor R, Ruffin DM, Benson LL.
    Arthritis Rheum; 1999 Aug 15; 42(8):1736-9. PubMed ID: 10446875
    [Abstract] [Full Text] [Related]

  • 17. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S.
    Clin Calcium; 2006 Nov 15; 16(11):1788-96. PubMed ID: 17079844
    [Abstract] [Full Text] [Related]

  • 18. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ.
    J Rheumatol; 2009 Aug 15; 36(8):1705-14. PubMed ID: 19487264
    [Abstract] [Full Text] [Related]

  • 19. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
    Suzuki Y, Wakabayashi T, Saito E, Yamada C, Suwa A.
    Clin Calcium; 2009 Mar 15; 19(3):404-15. PubMed ID: 19252251
    [Abstract] [Full Text] [Related]

  • 20. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Doga M, Mazziotti G, Bonadonna S, Patelli I, Bilezikian JP, Canalis E, Giustina A.
    J Endocrinol Invest; 2008 Jul 15; 31(7 Suppl):53-8. PubMed ID: 18791353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.